{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,2]],"date-time":"2026-05-02T12:45:10Z","timestamp":1777725910956,"version":"3.51.4"},"reference-count":17,"publisher":"SAGE Publications","issue":"12","license":[{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"},{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["J Int Med Res"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:p>Ovarian cancer remains the most lethal gynecological malignant tumor, with relapse occurring in approximately 70% of advanced cases. Anlotinib is an oral small-molecule multi-targeted tyrosine kinase inhibitor that can resist neoangiogenesis and inhibit tumor growth. Previous research demonstrated clinical antitumor activity of anlotinib in various cancers. We report the case of an elderly woman with advanced ovarian cancer who received anlotinib after failure of multiple-line chemotherapy. A partial response was observed after six cycles of anlotinib monotherapy, with a reduction in the size of the metastases and significantly decreased serum CA125 levels from 1832.7 U\/mL to 118.7 U\/mL. She continued to take anlotinib, with a progression-free survival time of more than 4 months. Only mild hypertension was observed during the treatment. Anlotinib monotherapy may be a novel therapeutic option for patients with advanced ovarian cancer.<\/jats:p>","DOI":"10.1177\/0300060520976824","type":"journal-article","created":{"date-parts":[[2020,12,10]],"date-time":"2020-12-10T12:44:22Z","timestamp":1607604262000},"update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":5,"title":["Successful treatment of advanced ovarian cancer with anlotinib: a case report"],"prefix":"10.1177","volume":"48","author":[{"given":"Ping","family":"Zhang","sequence":"first","affiliation":[{"name":"Department of Oncology, Dezhou People\u2019s Hospital, Dezhou, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Liangliang","family":"Ma","sequence":"additional","affiliation":[{"name":"Department of Oncology, Dezhou People\u2019s Hospital, Dezhou, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaojie","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Oncology, Dezhou People\u2019s Hospital, Dezhou, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ruijie","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Radiology, Dezhou People\u2019s Hospital, Dezhou, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2082-4627","authenticated-orcid":false,"given":"Yuting","family":"Dong","sequence":"additional","affiliation":[{"name":"Department of Oncology, Dezhou People\u2019s Hospital, Dezhou, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"179","published-online":{"date-parts":[[2020,12,7]]},"reference":[{"key":"e_1_3_3_2_2","first-page":"4626","article-title":"Expression and clinical significance of SLP-2 in ovarian tumors","volume":"17","author":"Zhang J","year":"2019","unstructured":"Zhang J, Song X, Li C, et\u00a0al. Expression and clinical significance of SLP-2 in ovarian tumors. Oncol Lett 2019; 17: 4626\u20134632.","journal-title":"Oncol Lett"},{"key":"e_1_3_3_3_2","doi-asserted-by":"publisher","DOI":"10.1186\/s13045-016-0332-8"},{"key":"e_1_3_3_4_2","first-page":"4510","article-title":"Knockdown of long non-coding RNA LINC00152 increases cisplatin sensitivity in ovarian cancer cells.","volume":"18","author":"Zou H","year":"2019","unstructured":"Zou H, Li H. Knockdown of long non-coding RNA LINC00152 increases cisplatin sensitivity in ovarian cancer cells. Exp Ther Med 2019; 18: 4510\u20134516.","journal-title":"Exp Ther Med"},{"key":"e_1_3_3_5_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00280-017-3501-8"},{"key":"e_1_3_3_6_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2015.65.8153"},{"key":"e_1_3_3_7_2","doi-asserted-by":"publisher","DOI":"10.1186\/s13568-019-0836-z"},{"key":"e_1_3_3_8_2","doi-asserted-by":"publisher","DOI":"10.1186\/s13045-018-0664-7"},{"key":"e_1_3_3_9_2","doi-asserted-by":"publisher","DOI":"10.1186\/s40880-019-0383-7"},{"key":"e_1_3_3_10_2","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdz264.002"},{"key":"e_1_3_3_11_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2019.37.4_suppl.95"},{"key":"e_1_3_3_12_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2019.37.15_suppl.6019"},{"key":"e_1_3_3_13_2","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdz247.077"},{"key":"e_1_3_3_14_2","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdz283.026"},{"key":"e_1_3_3_15_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2020.38.15_suppl.6061"},{"key":"e_1_3_3_16_2","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000020053"},{"key":"e_1_3_3_17_2","doi-asserted-by":"publisher","DOI":"10.1002\/cam4.1584"},{"key":"e_1_3_3_18_2","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.01562-2018"}],"container-title":["Journal of International Medical Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/0300060520976824","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1177\/0300060520976824","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/0300060520976824","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T10:44:05Z","timestamp":1777459445000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1177\/0300060520976824"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,12]]},"references-count":17,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["10.1177\/0300060520976824"],"URL":"https:\/\/doi.org\/10.1177\/0300060520976824","relation":{},"ISSN":["0300-0605","1473-2300"],"issn-type":[{"value":"0300-0605","type":"print"},{"value":"1473-2300","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,12]]},"article-number":"0300060520976824"}}